M&A Activity • Nov 6, 2025
M&A Activity
Open in ViewerOpens in native device viewer
Israel Canada (T.R) Ltd. (the "Company")
To: Israel Securities Authority www.isa.gov.il
To: Tel Aviv Stock Exchange Ltd. (TASE) www.tase.co.il
November 6, 2025
Further to the Company's immediate report dated September 30, 2025 (the Merger Transaction Report), regarding the merger transaction (as dened in the Merger Transaction Report); further to the Company's immediate report dated October 30, 2025, regarding receipt of a tax ruling and approval from nancing bodies for the merger transaction; and further to the approval of the merger transaction by the general meeting of DNA Group (T.R) Ltd. ('DNA') dated November 5, 2025 (collectively: the Reference Reports); the Company is pleased to update that on November 6, 2025, the approval of the Stock Exchange was obtained, and thus all precedent (suspensive) conditions to the merger transaction have been fullled.
The parties will act to complete the merger transaction in the coming days.
In addition, the Company updates that on November 6, 2025, entities from the Menora Insurance Group⁴ (Menora) notied Israel Canada Hotels of the exercise of 91,138 warrants, which can be exercised into 91,138 ordinary shares of Israel Canada Hotels, each with NIS 0.001 par value (the Exercise Shares), at an exercise price of NIS 304.13 per warrant, for a total consideration of approximately NIS 28 million (the Exercise Consideration). Accordingly, Israel Canada Hotels is allocating to Menora the Exercise Shares, against receipt of the Exercise Consideration.
For more details, see the Reference Reports and the DNA meeting invitation report of September 30, 2025⁵.
Terms not expressly dened in this report shall have the meanings ascribed to them in the Reference Reports.
Israel Canada (T.R) Ltd. Signed by: Guy Canada Deputy CEO
Page 1
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.